485 related articles for article (PubMed ID: 25535301)
21. The predictive value of TIMP-2 and IGFBP7 for kidney failure and 30-day mortality after elective cardiac surgery.
Esmeijer K; Schoe A; Ruhaak LR; Hoogeveen EK; Soonawala D; Romijn FPHTM; Shirzada MR; van Dissel JT; Cobbaert CM; de Fijter JW
Sci Rep; 2021 Jan; 11(1):1071. PubMed ID: 33441876
[TBL] [Abstract][Full Text] [Related]
22. Urinary TIMP-2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery.
Meersch M; Schmidt C; Van Aken H; Martens S; Rossaint J; Singbartl K; Görlich D; Kellum JA; Zarbock A
PLoS One; 2014; 9(3):e93460. PubMed ID: 24675717
[TBL] [Abstract][Full Text] [Related]
23. Assessment of cell-cycle arrest biomarkers to predict early and delayed acute kidney injury.
Bell M; Larsson A; Venge P; Bellomo R; Mårtensson J
Dis Markers; 2015; 2015():158658. PubMed ID: 25866432
[TBL] [Abstract][Full Text] [Related]
24. Cisplatin nephrotoxicity is not detected by urinary cell-cycle arrest biomarkers in lung cancer patients.
Toprak Z; Cebeci E; Helvaci SA; Toprak ID; Kutlu Y; Sakin A; Tukek T
Int Urol Nephrol; 2017 Jun; 49(6):1041-1047. PubMed ID: 28255639
[TBL] [Abstract][Full Text] [Related]
25. Current understanding and future directions in the application of TIMP-2 and IGFBP7 in AKI clinical practice.
Fan W; Ankawi G; Zhang J; Digvijay K; Giavarina D; Yin Y; Ronco C
Clin Chem Lab Med; 2019 Apr; 57(5):567-576. PubMed ID: 30179848
[TBL] [Abstract][Full Text] [Related]
26. Role of Urinary Kidney Stress Biomarkers for Early Recognition of Subclinical Acute Kidney Injury in Critically Ill COVID-19 Patients.
Casas-Aparicio G; Alvarado-de la Barrera C; Escamilla-Illescas D; León-Rodríguez I; Del Río-Estrada PM; Calderón-Dávila N; González-Navarro M; Olmedo-Ocampo R; Castillejos-López M; Figueroa-Hernández L; Peralta-Prado A; Luna-Villalobos Y; Piten-Isidro E; Fernández-Campos P; Ávila-Ríos S
Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204776
[TBL] [Abstract][Full Text] [Related]
27. A combined approach for the early recognition of acute kidney injury after adult cardiac surgery.
Zaouter C; Potvin J; Bats ML; Beauvieux MC; Remy A; Ouattara A
Anaesth Crit Care Pain Med; 2018 Aug; 37(4):335-341. PubMed ID: 29777769
[TBL] [Abstract][Full Text] [Related]
28. Serial Urinary Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 and the Prognosis for Acute Kidney Injury over the Course of Critical Illness.
McCullough PA; Ostermann M; Forni LG; Bihorac A; Koyner JL; Chawla LS; Shi J; Kampf JP; McPherson P; Kellum JA;
Cardiorenal Med; 2019; 9(6):358-369. PubMed ID: 31618746
[TBL] [Abstract][Full Text] [Related]
29. Validation of cell-cycle arrest biomarkers for acute kidney injury after pediatric cardiac surgery.
Meersch M; Schmidt C; Van Aken H; Rossaint J; Görlich D; Stege D; Malec E; Januszewska K; Zarbock A
PLoS One; 2014; 9(10):e110865. PubMed ID: 25343505
[TBL] [Abstract][Full Text] [Related]
30. Urinary [TIMP-2]·[IGFBP7]-guided randomized controlled intervention trial to prevent acute kidney injury in the emergency department.
Schanz M; Wasser C; Allgaeuer S; Schricker S; Dippon J; Alscher MD; Kimmel M
Nephrol Dial Transplant; 2019 Nov; 34(11):1902-1909. PubMed ID: 29961888
[TBL] [Abstract][Full Text] [Related]
31. Impact of Isolyte Versus 0.9% Saline on Postoperative Event of Acute Kidney Injury Assayed by Urinary [TIMP-2] × [IGFBP7] in Patients Undergoing Cardiac Surgery.
Lee NM; Deriy L; Petersen TR; Shah VO; Hutchens MP; Gerstein NS
J Cardiothorac Vasc Anesth; 2019 Feb; 33(2):348-356. PubMed ID: 30181085
[TBL] [Abstract][Full Text] [Related]
32. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury.
Kashani K; Al-Khafaji A; Ardiles T; Artigas A; Bagshaw SM; Bell M; Bihorac A; Birkhahn R; Cely CM; Chawla LS; Davison DL; Feldkamp T; Forni LG; Gong MN; Gunnerson KJ; Haase M; Hackett J; Honore PM; Hoste EA; Joannes-Boyau O; Joannidis M; Kim P; Koyner JL; Laskowitz DT; Lissauer ME; Marx G; McCullough PA; Mullaney S; Ostermann M; Rimmelé T; Shapiro NI; Shaw AD; Shi J; Sprague AM; Vincent JL; Vinsonneau C; Wagner L; Walker MG; Wilkerson RG; Zacharowski K; Kellum JA
Crit Care; 2013 Feb; 17(1):R25. PubMed ID: 23388612
[TBL] [Abstract][Full Text] [Related]
33. Economic and clinical benefits of early identification of acute kidney injury using a urinary biomarker.
Berdugo MA; Kirson NY; Zimmer L; Beyhaghi H; Toback S; Scarpati LM; Stone MN; Dember R; Tseng-Tham J; Wen J; Miller M
J Med Econ; 2019 Dec; 22(12):1281-1289. PubMed ID: 31234668
[No Abstract] [Full Text] [Related]
34. The diagnostic accuracy of urinary [TIMP-2]·[IGFBP7] for acute kidney injury in adults: A PRISMA-compliant meta-analysis.
Liu C; Lu X; Mao Z; Kang H; Liu H; Pan L; Hu J; Wang L; Zhou F
Medicine (Baltimore); 2017 Jul; 96(27):e7484. PubMed ID: 28682920
[TBL] [Abstract][Full Text] [Related]
35. [Construction of a risk predictive model of acute kidney injury based on urinary tissue inhibitor of metalloproteinase 2 and insulin-like growth factor-binding protein 7 and its early predictive value in critically ill patients].
Wang H; Mou H; Xu X; Zheng R
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2024 Apr; 36(4):387-391. PubMed ID: 38813633
[TBL] [Abstract][Full Text] [Related]
36. The effectiveness of urinary TIMP-2 and IGFBP-7 in predicting acute kidney injury in critically ill neonates.
Chen J; Sun Y; Wang S; Dai X; Huang H; Bai Z; Li X; Wang J; Li Y
Pediatr Res; 2020 May; 87(6):1052-1059. PubMed ID: 31791043
[TBL] [Abstract][Full Text] [Related]
37. Comparison of urinary TIMP-2 and IGFBP7 cut-offs to predict acute kidney injury in critically ill patients: A PRISMA-compliant systematic review and meta-analysis.
Zhang D; Yuan Y; Guo L; Wang Q
Medicine (Baltimore); 2019 Jun; 98(26):e16232. PubMed ID: 31261582
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic Value of Urine Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 for Acute Kidney Injury: A Meta-Analysis.
Su Y; Gong Z; Wu Y; Tian Y; Liao X
PLoS One; 2017; 12(1):e0170214. PubMed ID: 28107490
[TBL] [Abstract][Full Text] [Related]
39. Clinical Use of the Urine Biomarker [TIMP-2] × [IGFBP7] for Acute Kidney Injury Risk Assessment.
Vijayan A; Faubel S; Askenazi DJ; Cerda J; Fissell WH; Heung M; Humphreys BD; Koyner JL; Liu KD; Mour G; Nolin TD; Bihorac A;
Am J Kidney Dis; 2016 Jul; 68(1):19-28. PubMed ID: 26948834
[TBL] [Abstract][Full Text] [Related]
40. Clinical adjudication in acute kidney injury studies: findings from the pivotal TIMP-2*IGFBP7 biomarker study.
Liu KD; Vijayan A; Rosner MH; Shi J; Chawla LS; Kellum JA
Nephrol Dial Transplant; 2016 Oct; 31(10):1641-6. PubMed ID: 27342580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
